These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1631937)

  • 1. Prolongation of skin allograft survival in mice by didemnin B.
    Alfrey EJ; Zukoski CF; Montgomery DW
    Transplantation; 1992 Jul; 54(1):188-9. PubMed ID: 1631937
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of didemnin B in suppressing allograft rejection in mice and rats.
    Yuh DD; Zurcher RP; Carmichael PG; Morris RE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1141-3. PubMed ID: 2650081
    [No Abstract]   [Full Text] [Related]  

  • 3. Didemnin B prolongs rat heart allograft survival.
    Stevens DW; Jensen RM; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1139-40. PubMed ID: 2650080
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin transplantation in mice and dogs. Effect of cyclosporin A and dihydrocyclosporin C.
    Borel JF; Meszaros J
    Transplantation; 1980 Feb; 29(2):161-2. PubMed ID: 6986689
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of allograft survival by cyclosporin A.
    Cosimi AB; Shield CF; Peters C; Burton RC; Scott G; Russell PS
    Surg Forum; 1979; 30():287-9. PubMed ID: 120019
    [No Abstract]   [Full Text] [Related]  

  • 6. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K; Hoshino Y; Suzuki C; Masubuchi Y; Yanagawa Y; Ohtsuki M; Sasaki S; Fujita T
    Transplant Proc; 1996 Apr; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy.
    Nawrocki G; Grieb P; Górski A; Danielewicz R; Rowiński W
    Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of skin allograft survival in mice following administration of ALLOTRAP.
    Buelow R; Veyron P; Clayberger C; Pouletty P; Touraine JL
    Transplantation; 1995 Feb; 59(4):455-60. PubMed ID: 7878745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 11. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
    Schorlemmer HU; Seiler FR; Bartlett RR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):763-7. PubMed ID: 8438472
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin A.
    Lancet; 1979 Oct; 2(8146):779-80. PubMed ID: 90866
    [No Abstract]   [Full Text] [Related]  

  • 15. Early experience with cyclosporine: a historic perspective.
    Kostakis A
    Transplant Proc; 2004 Mar; 36(2 Suppl):22S-24S. PubMed ID: 15041302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract]   [Full Text] [Related]  

  • 18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits.
    Chaves DN; Petroianu A; Alberti LR; Pereira WA
    Transplant Proc; 2004 May; 36(4):1018-20. PubMed ID: 15194354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.